Browse the full management transaction log of HeartWare International, Inc., a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was filed on 9 February 2016 (Levée d'options). Among the most active insiders: Schuermann James. All data is free.
21
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
16 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HeartWare International, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,991 of 24,987 companies
27.6
score / 100
Value
22
Quality
33
FCF yld-4.9%
Earn yld-3.5%
EV/EBITDA·
ROE-28%
Gross mgn63%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
HeartWare International, Inc. is a company focused on developing medical devices for the treatment of heart diseases. It primarily concentrates on cardiac support systems for patients with heart failure.